OB/GYN 904 - OB/GYN Clinical Alert - Apr 01, 2005

Target Audience:

This activity is intended for the obstetrician and gynecologist.


AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Leon Speroff, MD
Professor of Obstetrics and Gynecology
Oregon Health and Science University

Associate Editors
Sarah L. Berga, MD
James Robert McCord Professor and Chair
Department of Gynecology and Obstetrics
Emory University
School of Medicine

Robert L. Colemen, MD
Associate Professor
University of Texas; M.D.
Anderson Cancer Center

John C. Hobbins, MD
Professor and Chief of Obstetrics
University of Colorado Health Sciences Center

Frank W. Ling, MD
Women?s Health Specialists, PLLC
Memphis, Tennessee


  • Non-Invasive Prenatal Diagnosis Screening
  • Does Practice Make Perfect?
  • Does It Matter How Ovaries Removed Prophylactically Are Processed Pathologically?
  • The WHI Results on Urinary Incontinence
  • The Length of Third Stage of Labor and Risk of Postpartum Hemorrhage
  • Validating Intraoperative Pathology: Frozen Section


  • to present the latest drug data regarding diagnosis and treatment of various diseases affecting women, including cancer, sexually transmitted diseases, and osteoporosis
  • present new data concerning prenatal care and complications, as well as neonatal health
  • discuss the pros and cons and cost-effectiveness of new testing procedures

Financial Disclosure:

In order to reveal any potential bias in this publication, and in accordance with Accreditation Council for Continuing Medical Education guidelines, we disclose that Leon Speroff, MD (editor) is involved as a consultant, and does research for, Wyeth Ayerst, Pfizer, Ortho, and Novo Nordisk.

Sarah L. Berga, MD (associate editor) is a consultant for Pfizer, Organon, and Women First, Inc., and is involved in research for Berlex and Health Decisions, Inc.

Robert L. Coleman, MD (associate editor) is on the speaker’s bureau for GlaxoSmithKline, Bristol Myers Squibb, and Ortho Biotech.

John C. Hobbins, MD and Frank W. Ling, MD (associate editors) report no relationships related to this field of study.

Copyright 2005 AHC Media. All rights reserved.